The question is no longer whether culture impacts performance, but whether a company chooses to manage its influence ...

Behind the rise of a country once labeled as a "nation of knockoffs" to a technological powerhouse that has overtaken South Korea and now threatens the United States within just over a decade lies a ...

Novartis will launch a direct-to-patient (DTP) platform in the US on November 1, 2025, starting with Cosentyx, which will be offered at a 55% dis ...